Objective: To assess the effects of plant sterol or stanol ester consumption on their incorporation into erythrocytes and their effects on osmotic fragility of red blood cells. Design: Double-blind, randomized, placebo-controlled intervention trial. Subjects and intervention: Forty-one subjects on stable statin treatment -who already have increased serum plant sterol and stanol concentrations -first received for 4 weeks a control margarine. For the next 16 weeks, subjects were randomly assigned to one of three possible interventions. Eleven subjects continued with control margarine, 15 subjects with plant sterol ester enriched and 15 subjects with plant stanol ester-enriched margarine. Daily plant sterol or stanol intake was 2.5 g. Erythrocyte haemolysis was measured spectrophotometrically at five different saline concentrations. Results: Despite significant (P ¼ 0.004) increases of, respectively, 42 and 59% in cholesterol-standardized serum sitosterol and campesterol concentrations in the plant sterol group as compared to the control group, campesterol levels in the red blood cells did not change (P ¼ 0.196). Osmotic fragility did not change significantly (P ¼ 0.757) in the plant sterol and plant stanol groups as compared to the control group. Conclusion: We conclude that plant sterol and stanol ester consumption for 16 weeks does not change osmotic fragility of erythrocytes in statin-treated patients.
Introduction
Plant sterols and stanols are cholesterol-like compounds that lower intestinal cholesterol absorption and consequently serum low-density lipoprotein cholesterol concentrations (Katan et al., 2003) . Functional foods enriched with plant sterols and stanols are therefore widely available in many countries. Until now, however, most research has focused on the cholesterol-lowering properties of plant sterols and stanols.
Compared to cholesterol, only small amounts of plant sterols and stanols are absorbed by the intestine (Ostlund et al., 2002) . Nonetheless, in patients on statin therapy, plasma plant sterol and stanol concentrations are two-fold increased . Animal studies have now shown that plant sterols and stanols are incorporated into various tissues like the colon, liver, spleen and heart (Sanders et al., 2000) , which may have functional consequences. Indeed, some authors have reported effects of plant sterol and stanol consumption on various kinds of cancers and immune status (as reviewed by de Jong et al., 2003) . Red blood cells also incorporate plant sterols into their membranes (Bruckerdorfer et al., 1969) , which may make erythrocytes less deformable and more fragile. For example, Naito et al. (2000) showed increased osmotic fragility in stroke-prone spontaneously hypertensive (SHRSP) rats after canola oil consumption, which is rich in plant sterols. Ratnayake et al. (2000) showed decreased red blood cell deformability in SHRSP rats after plant sterol consumption. Deformability of red blood cells is necessary to enable them to pass through the smallest arterioles and capillaries to supply all organs and tissues with oxygen. Furthermore, erythrocytes need to be resistant to osmotic pressure to prevent haemolysis. Serum plant sterol and stanol concentrations in these rat studies (Naito et al., 2000; Ratnayake et al., 2000) , however, were 40-80 times higher as compared to physiological concentrations in humans. The question therefore remains whether these findings can be extrapolated to humans consuming plant sterol or stanolenriched functional foods. As particularly patients on statin treatment have elevated serum plant sterol concentrations , the purpose of the present study was to examine the effect of plant sterol or stanol consumption on red blood cell osmotic fragility in subjects on stable statin treatment.
Methods
Subjects Forty-one subjects, 21 women and 20 men, participated in the study. All subjects were recruited via local newspaper advertisements and were on stable statin treatment (simvastatin, atorvastatin or pravastatin) for at least 6 months before entering the study. Subjects with cholesterol-lowering medication other than statins or with clinical manifestations of liver disorders, cardiovascular disease during the previous 5 years and diabetes mellitus were excluded. Their age was 58.578.3 years (mean7s.d.), their body mass index 26.872.6 kg/m 2 , whereas their serum total cholesterol concentrations were 5.270.8 mmol/l and serum triacylglycerol concentrations were 1.470.7 mmol/l. Seven subjects used b-blockers, eight subjects angiotensin converting enzyme inhibitors, seven subjects calcium antagonists, three subjects angiotensin II antagonists and six subjects multivitamin complexes. The use of drugs and multivitamins did not change during the study and were equally divided over the three groups. The Medical Ethics Review Committee of the Maastricht University approved the present study and all subjects signed for informed consent.
Study design
During a run-in period of 4 weeks, each subject consumed a light margarine (40% fat) with no added plant sterol or stanol esters. After the run-in period, the subjects were randomly divided into three different groups. For a period of 16 weeks, the first group continued to consume control margarine, whereas the second and third groups consumed margarine enriched with, respectively, plant sterol esters or plant stanol esters. The composition of the three different margarines is shown in Table 1 . Divided over at least two meals, the subjects consumed daily 30 g of margarine, which provided 2.5 g plant sterols or stanols. Plant sterols and stanols were provided as their fatty acid esters, made by transesterification of free plant sterols and stanols with rapeseed oil fatty acids. The vegetable oil-derived plant sterols contained mainly sitosterol (48%), campesterol (27%), stigmasterol (15%) and brassicasterol (5%). The plant stanol mixture was obtained by saturation of these sterols, giving mainly sitostanol (65%) and campestanol (30%) (Raisio Group, Raisio, Finland). The total energy intake for all subjects at the end of the run-in period, as determined by a food frequency questionnaire (Plat and Mensink, 2000) , was 9.171.7 MJ. Fat intake was 35.375.5 energy percent as fat, carbohydrate intake 45.677.3% and protein intake 17.172.2%. Energy intake as well as the macronutrient composition of the diets did not change during the study (data not shown).
Measurements
Blood sampling. Blood samples were taken after an overnight fast at the end of the run-in period (weeks 3 and 4) and at the end of the intervention period (weeks 19 and 20). On the morning of blood sampling, subjects were not allowed to smoke. Venepuncture was performed in the antecubital vein with a vacutainer system using 0.8 Â 38 mm 2 sterile needles.
Blood was sampled in serum separator tubes for analysis of plant sterol and stanol concentrations, and in heparin tubes for analysing osmotic fragility and red blood cell sterol levels. In addition, serum was obtained for analysis of lipids and lipoproteins and ethylenediaminetetraacetic acidplasma for analysis of other cardiovascular risk markers (to be published elsewhere). All tubes and needles were from Becton, Dickinson and Company (New Jersey, USA).
Osmotic fragility. Osmotic fragility was determined at the end of the control and intervention period according to the Parpart method with the adjustment by Godal et al. (1980) . Briefly, a stock solution was prepared of 90.0 g NaCl, 13.66 g Na 2 HPO 4 Á 2H 2 O and 2.43 g NAH 2 PO 4 Á 2H 2 O and 1 l of distilled water. The stock solution was diluted with distilled water to five different saline concentrations of 0.10, 0.35, 0.40, 0.45 and 0.50% (w/w) NaCl. After venepuncture, the heparin tube was slowly inverted 10 times. Then, 20 ml blood was mixed with 2 ml of each of the five NaCl solutions and set aside at 201C in a water bath for 30 min. Then the samples were gently mixed again and centrifuged at 2000 g for 10 min. Two hundred microlitres of the supernatant of each tube was transferred to a sterile 96-well polylactate strip plate (Greiner Labortechnik, Frickenhausen, Germany). The haemoglobin concentration of the supernatant was read in a microplate reader (model 450; Bio-Rad laboratories, Richmond, UK) at a wavelength of 540 nm. The tube containing the lowest NaCl concentration (i.e. 0.10% NaCl) represented the value for 100% haemolysis. Analyses were performed in duplo and averaged. The computer program Kaleidagraph for Mac Os X (Synergy Software, Reading, MA, USA) was used to calculate the NaCl concentration at which 50% haemolysis occurred (EC 50 ).
Serum and red blood cell plant sterol and stanol concentrations. Serum and red blood cell plant sterol (sitosterol, campesterol), plant stanol (sitostanol, campestanol) and cholesterol concentrations were analysed by gas chromatography (GC) as described before (Plat and Mensink, 2001) . Serum samples of weeks 3 and 4, and weeks 19 and 20 were pooled before analysis, and samples of one subject were analysed in the same analytical run. Before analysis of the erythrocytes, heparin tubes were centrifuged for 10 min at 2000 g and then red blood cells were washed twice with phosphate buffered saline and stored at À801C until analysis. Serum plant sterol and stanol concentrations were expressed as Â 10 2 mmol/mmol cholesterol, whereas cholesterol, plant sterol and stanol levels of the red blood cell were expressed per mg protein. The protein content of the red blood cells was determined as described (Lowry et al., 1951) .
Statistics
Differences for EC 50 NaCl and serum plant sterol and stanol concentrations between groups were analysed by analysis of variance. When the analyses indicated a significant effect of diet (Po0.05), the diets were compared pairwise. Between diet comparisons were corrected for three-group comparisons by the Bonferroni correction (Po0.017). Values are expressed as means7s.d. All analyses were performed in SPPS 11 for Mac Os X (SPSS Inc., Chigaco, IL, USA). Before the start of the study, it was calculated that the statistical power to detect a true difference in EC 50 of at least 0.015% NaCl (3.5%) (s.d. ¼ 0.010% NaCl) at a significance level of a ¼ 0.017 was more than 80%. Such an effect can be obtained by dietary means, as shown by Candan and Gultekin (2002) In that study, the EC 50 for osmotic fragility increased by 0.029% NaCl (6%) after zinc supplementation and by 0.061% NaCl (13%) after supplementation vitamin C supplementation. Associations between parameters were evaluated by calculating Pearson's correlation coefficients.
Results
The average NaCl concentration for 50% (EC 50 ) haemolysis of the erythrocytes was 0. 43370.017% in the control group, 0.42970.011% in the sterol group and 0.42770.009% NaCl in the stanol group (Figure 1) . At the end of the intervention period, these values were, respectively, 0.43370.009, 0.43470.014 and 0.43570.015% NaCl. Changes in osmotic fragility in the plant sterol and stanol groups were not significantly different from the changes in the control group (P ¼ 0.782). Serum cholesterol-standardized campesterol concentrations significantly increased in the plant sterol group by 59% as compared to the control group (P ¼ 0.004) and by 85% as compared to the plant stanol group (Po0.001) ( Table 2 ). Serum cholesterol-standardized sitosterol concentrations increased by 42% in the plant sterol group as compared to the control group (P ¼ 0.022) and by 65% as compared to the stanol group (Po0.001). Cholesterolstandardized sitostanol and campestanol concentrations did not change significantly in any of the groups. Changes in protein-standardized red blood cells campesterol concentrations in the plant sterol and stanol groups were not significantly (P ¼ 0.196) different from the control group (Table 3) . Also protein-standardized red blood cell cholesterol concentrations did not change significantly (P ¼ 0.544). Concentrations of sitosterol and plant stanols were too low to be measured accurately.
Both baseline values and changes in osmotic fragility were not significantly correlated to baseline values and changes in serum cholesterol-standardized plant sterol or plant stanol concentrations. In addition, osmotic fragility was also not correlated to campesterol and cholesterol concentrations of the red blood cells. Baseline values of cholesterol-standardized serum campesterol were significantly correlated with erythrocyte campesterol (mmol/mg protein) concentrations (r ¼ 0.37, P ¼ 0.026).
Discussion
In the present study, plant sterol and stanol ester consumption for 16 weeks did not change osmotic fragility of red blood cells from subjects on stable statin therapy. We further found that serum concentrations of campesterol and sitosterol were increased in the plant sterol group, while red blood cell campesterol levels did not change. Animal studies (Naito et al., 2000; Ratnayake et al., 2003) , as well as clinical features of sitosterolaemic patients, who are characterized by high plasma plant sterol concentrations (Bjorkhem and Boberg, 1994) , have however suggested unfavourable effects of increased plant sterol concentrations on erythrocyte properties. In agreement with our results, however, Jenkins et al. (2002) found no effect on osmotic fragility in hyperlipidaemic subjects of a combined intake of plant sterols, viscous fibres and vegetable proteins. Also, consumption of plant sterol-enriched margarine for 52 weeks did not decrease red blood cell deformability in healthy subjects, despite significant increases in red blood cell campesterol and b-sitosterol levels (Hendriks et al., 2003) . In our study, however, the slight increase in campesterol levels in the red blood cells did not reach statistical significance. This discrepancy in findings with the study of Hendriks et al. may be related to differences in study design, such as study population and duration of the studies. Taken together, these findings do not suggest that products rich in plant sterols or stanols have an effect on osmotic fragility and deformability of erythrocytes in humans.
In contrast, studies in the SHRSP rat model did show unfavourable effects on erythrocyte deformability (Ratnayake et al., 2000) and osmotic fragility (Naito et al., 2000 (Naito et al., , 2003 after consumption of canola oil, which is abundant in plant sterols. A change in erythrocyte properties can be attributed to both a decrease in cholesterol levels of the red blood cell membrane as well as to an increase in plant sterol levels in the membrane (Naito et al., 2003) . Indeed, an in vitro study showed that replacement of cholesterol in the erythrocyte membrane by various other sterols increased osmotic fragility (Bruckerdorfer et al., 1969) . Our results, however, showed that consumption of plant sterols and stanols at recommended intakes did not have an impact on red blood cell cholesterol levels. Ketomaki et al. (2003) also found that in children with hypercholesterolaemia red blood cell cholesterol levels did not change after consumption of plant sterols (2 g/day) for 4 weeks, although campesterol and sitosterol levels of the red blood cells increased. Therefore, it is questionable whether in humans plant sterol or stanol ester consumption lowers cholesterol levels in red blood cell membranes. In the SHRSP rat model, however, red blood cell cholesterol concentrations were reduced to the same extent in the plant sterol-and stanol-fed rats, but erythrocyte deformability was only unfavourably affected in the plant sterol group. Thus, there is also no unequivocal evidence from in vivo studies that cholesterol depletion itself changes erythrocyte function.
It is also not clear if cell membrane levels of plant sterols or stanols change erythrocyte function. In the SHSPR rats fed plant sterols, red blood cell levels of plant sterols were significantly higher as compared to the control group. In the plant stanol-fed group, levels were significantly lower. Red blood cell deformability was, however, only decreased in the plant sterol group, whereas the lifespan was more shortened in the plant stanol-fed rats (Ratnayake et al., 2003) . In the same rat model, osmotic fragility was also increased after canola oil consumption (Naito et al., 2000 (Naito et al., , 2003 . However, these effects were not found in hamsters fed plant stanol esters (Ebine et al., 2005) . In contrast, osmotic fragility was even improved in a study with apolipoprotein E-deficient Erythrocyte osmotic fragility in patients on statin treatment A de Jong et al mice during plant sterol consumption (Moghadasian et al., 1999) . These contradictory findings suggest that these effects are species specific and negative findings have only been reported for SHRSP rats. These animal have a mutation in the ABCG5 gene (Scoggan et al., 2003) that causes sitosterolaemia in both rats and humans (Lu et al., 2001) . As already mentioned, sitosterolaemic patients have an increased erythrocyte osmotic fragility (Bjorkhem and Boberg, 1994) . Possibly the extreme high plasma plant sterol concentrations in these patients as well as in SHRSP rats are related to red blood cell dysfunction. It is, however, also possible that another mechanism, independent of cholesterol or plant sterol content of the red blood cell membrane, is involved. In support, it was recently suggested that not plant sterols, but other factors, are responsible for the decreased survival time in SHRSP rats after consumption of canola oil (Tatematsu et al., 2004) . In support of this, the lifespan of salt-loaded SHRSP rats fed a diet rich in canola oil was shorter than that of SHRSP rats fed a soybean oil-rich diet. The amount of plant sterols in the two oils was similar (Ogawa et al., 2003) . Finally, other genetic mutations in SHRSP rats (Chen et al., 2005) may contribute to the dietary effects on osmotic fragility and lifespan in these animals. Except for the sterol composition of membranes, oxidative stress may also increase osmotic fragility of red blood cells (Srour et al., 2000) . As plant sterol or stanol consumption decreases serum concentrations of fat-soluble antioxidants (Plat and Mensink, 2001) , it can be speculated that this leads to increased oxidative stress and hence to increased osmotic fragility. However, even if consumption of plant sterols or stanols increases oxidative stress, our study shows that this is not accompanied by a change in osmotic fragility.
In conclusion, plant sterol or plant stanol ester consumption for 16 weeks did not change osmotic fragility in patients on current statin treatment. To what extent these findings can be extrapolated to other population groups, like for example type II diabetics, who already may have fragile erythrocytes (Suhail and Rizvi, 1987) , needs further investigation. However, our results do suggest that the findings in SHRSP rats (Ratnayake et al., 2003) may not be relevant for the majority of the population.
